Corcept Therapeutics (CORT) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $93.25 +0.33%
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q1 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $57.7 million versus the consensus estimate of $58.18 million.
GUIDANCE:
Corcept Therapeutics sees Q2 2018 revenue of $275-300 million, versus the consensus of $290.2 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- Simulations Plus (SLP) Tops Q3 EPS by 7c
- Northern Technologies (NTIC) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
